{"gene":"S1PR1","run_date":"2026-04-28T20:42:06","timeline":{"discoveries":[{"year":1998,"finding":"EDG1/S1PR1 is a functional Gi/o-coupled GPCR for sphingosine-1-phosphate that activates phospholipase C, mobilizes intracellular Ca2+, activates Ras-MAPK, and inhibits adenylate cyclase; all responses are pertussis toxin-sensitive.","method":"Stable transfection in CHO and HEL cells, radioligand binding, pertussis toxin treatment, Ca2+ mobilization assay, IP production assay, MAPK activation assay, cAMP assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in heterologous cells with multiple orthogonal assays and pharmacological controls","pmids":["9765227"],"is_preprint":false},{"year":1999,"finding":"EDG1/S1PR1 couples preferentially to Gi (not Gq) as demonstrated in a Xenopus oocyte expression system; co-expression with chimeric Gαqi protein was required to confer S1P-responsive intracellular calcium transients, whereas EDG-3 and EDG-5 directly coupled to Gq pathway.","method":"Xenopus oocyte mRNA microinjection, chimeric G-protein co-expression, calcium transient recording","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — defined G-protein coupling via reconstitution with chimeric Gα proteins in a defined expression system","pmids":["10383399"],"is_preprint":false},{"year":1999,"finding":"Ligand-induced trafficking of EDG-1/S1PR1: SPP specifically induces reversible receptor translocation from the plasma membrane to perinuclear endocytic vesicles/lysosomes (t1/2 ~15 min internalization, ~30 min recycling); C-terminal truncation completely blocks internalization.","method":"EDG-1-GFP chimera live imaging in HEK293 cells, colocalization with endocytic markers, SPP dose-response, C-terminal truncation mutants","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 1–2 — direct live imaging with GFP chimera, domain mapping by truncation mutagenesis","pmids":["10198065"],"is_preprint":false},{"year":2000,"finding":"EDG1/S1PR1 mediates S1P-induced migration and Rac activation; Edg1-/- mouse embryonic cells fail to activate Rac in response to S1P and exhibit defective migration, leading to vascular maturation defects due to loss of vascular smooth muscle cells/pericytes.","method":"Germline knockout mouse model, vascular phenotyping, Rac GTPase activation assay, cell migration assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function in mice with defined cellular and molecular phenotype replicated across multiple assays; 977 citations","pmids":["11032855"],"is_preprint":false},{"year":2000,"finding":"EDG1/S1PR1 (but not EDG5) signals via PI3-kinase and Rac to promote chemotaxis and membrane ruffling; EDG5 instead inhibits Rac by stimulating Rac-GTPase-activating protein activity, establishing receptor subtype-specific regulation of Rac.","method":"CHO cells stably expressing EDG1, EDG3, or EDG5; chemotaxis assay, membrane ruffle quantification, GTP-Rac pulldown, PI3K assay, pertussis toxin and dominant-negative Cdc42/Rho constructs","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution in defined cell lines with multiple signaling assays and dominant-negative constructs; 275 citations","pmids":["11094076"],"is_preprint":false},{"year":2000,"finding":"Computational modeling and site-directed mutagenesis identified Arg120, Arg292 (ion-pairing with the phosphate of S1P), and Glu121 (ion-pairing with the ammonium group) as critical ligand-recognition residues of EDG-1/S1PR1.","method":"Computational homology modeling, site-directed mutagenesis, radioligand binding, [35S]GTPγS binding, receptor internalization assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — computational model validated by multiple functional mutagenesis assays","pmids":["10982820"],"is_preprint":false},{"year":2001,"finding":"A single residue difference (Glu vs. Gln at the homologous position) determines ligand specificity between S1P1/EDG1 (Glu required for S1P recognition) and LPA1/EDG2; Glu/Gln interchange point mutants confirmed this prediction.","method":"Computational modeling, site-directed mutagenesis of S1P1 and LPA1, ligand-binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — structure-function mutagenesis with clear mechanistic interpretation","pmids":["11604399"],"is_preprint":false},{"year":2001,"finding":"EDG1/S1PR1 phosphorylation and internalization are regulated by two independent mechanisms: agonist-induced GRK2 phosphorylation (on C-terminal serine/threonine residues) drives internalization, whereas PKC/PMA-induced phosphorylation causes surface loss via a distinct pathway; removal of 12 C-terminal residues specifically blocks agonist-mediated internalization but not PMA-mediated phosphorylation.","method":"Phosphoamino acid analysis, in vitro GRK2 kinase assay, C-terminal truncation mutants, surface expression assay in intact cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assay plus domain mutagenesis with multiple mechanistic readouts","pmids":["11741892"],"is_preprint":false},{"year":2001,"finding":"EDG-1/S1PR1 mediates S1P-induced cardiac myocyte hypertrophy primarily via Gi, activating ERK, p38 MAPK, JNK, PI3K/Akt, and Rho/actin stress fiber pathways; anti-EDG1 antibodies blocked S1P-induced hypertrophy in neonatal rat cardiomyocytes.","method":"Neonatal rat cardiomyocyte culture, anti-EDG1 antibody blocking, phospho-Western blot, kinase inhibitors, [3H]-phenylalanine incorporation, cell size measurement","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — antibody blocking and kinase inhibitor pharmacology with multiple signaling readouts; single lab","pmids":["11549339"],"is_preprint":false},{"year":2002,"finding":"EDG-1/S1PR1 is N-glycosylated at Asn30 in its extracellular N-terminus; this glycosylation is required for ligand-induced receptor internalization and for localization to caveolae microdomains, but not for ligand binding or MAPK activation.","method":"N30D mutagenesis, sucrose density gradient fractionation, ligand binding assay, MAPK activation assay, internalization assay","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1 — site-directed mutagenesis with multiple orthogonal functional assays","pmids":["12087059"],"is_preprint":false},{"year":2010,"finding":"STAT3 directly transcribes the S1PR1 gene; S1PR1 reciprocally activates STAT3 by upregulating JAK2 tyrosine kinase activity, and S1P-S1PR1-induced STAT3 activation is persistent (vs. transient IL-6-induced activation), forming a positive feedback loop for sustained STAT3 activity in tumor cells.","method":"ChIP assay, siRNA knockdown, reporter assay, Western blot for JAK2/pSTAT3, tumor xenograft models","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP for direct transcription factor binding, functional rescue experiments, in vitro and in vivo models; 339 citations","pmids":["21102457"],"is_preprint":false},{"year":2011,"finding":"GRK2 mediates agonist-induced S1PR1 desensitization on blood-exposed lymphocytes; GRK2 deficiency impairs lymphocyte movement from blood into lymphoid tissues, and this block is rescued in S1P-deficient mice. B cell movement between marginal zone and follicles requires GRK2-dependent S1PR1 desensitization.","method":"Conditional GRK2 knockout mice, adoptive transfer experiments, S1P-deficient mouse rescue, S1PR1 desensitization motif point mutant","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with conditional knockouts and point-mutant rescue; 170 citations","pmids":["21960637"],"is_preprint":false},{"year":2012,"finding":"S1PR1 on megakaryocytes directs proplatelet extension into bone marrow sinusoids by sensing the S1P gradient; conditional S1PR1-deficient mice develop severe thrombocytopenia due to aberrant extravascular proplatelet formation and defective intravascular shedding.","method":"Conditional knockout mice, intravital multiphoton microscopy, platelet counts, bone marrow histology","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with intravital imaging and defined cellular phenotype; 126 citations","pmids":["23148237"],"is_preprint":false},{"year":2012,"finding":"Smad2/3 signaling in endothelial cells maintains vascular integrity by regulating S1PR1 and N-cadherin expression; endothelial-specific Smad2/3 double KO results in reduced S1PR1 expression, gaps between ECs and mural cells, and embryonic hemorrhage.","method":"Tie2-Cre conditional double knockout mice, immunostaining, Western blot for S1PR1 and adhesion proteins","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with molecular readout; single lab","pmids":["22498737"],"is_preprint":false},{"year":2012,"finding":"S1PR1-STAT3 signaling in myeloid cells enables intravasation and formation of premetastatic niches; targeting S1PR1 or STAT3 in myeloid cells disrupts existing premetastatic niches.","method":"Myeloid-specific conditional knockouts, flow cytometry, tumor metastasis models","journal":"Cancer cell","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological targeting with mechanistic readout; single lab","pmids":["22624714"],"is_preprint":false},{"year":2013,"finding":"KLF2 transcriptionally drives S1PR1 expression in T cells; TGF-β, IL-33, and TNF suppress KLF2 via PI3K/Akt signaling, thereby downregulating S1PR1 and enabling tissue-resident memory CD8+ T cell establishment. Forced S1PR1 expression prevents TRM cell formation.","method":"Retroviral forced expression of S1PR1 in T cells, cytokine treatment, transcription factor knockdown, mouse adoptive transfer models","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — forced expression and genetic epistasis with defined transcriptional mechanism; 680 citations","pmids":["24162775"],"is_preprint":false},{"year":2013,"finding":"S1PR1 forms a complex with c-Met and integrin β4 in caveolin-enriched lipid rafts; HGF-induced c-Met activation leads to S1PR1 transactivation and Rac1 activation, which are rate-limiting for endothelial barrier enhancement.","method":"Co-immunoprecipitation, siRNA knockdown of S1PR1 and ITGB4, transendothelial electrical resistance measurement, c-Met inhibitor XL880","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal co-IP and siRNA with functional readout; single lab","pmids":["23212923"],"is_preprint":false},{"year":2014,"finding":"Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling in T cells at low S1P concentrations near lymphoid organ exit sites; dynamin 2-deficient T cells can only generate a transient pulse of S1PR1 signaling insufficient for egress.","method":"T cell-specific dynamin 2 knockout mice, transgenic S1PR1 rescue, lymphocyte egress assay, thymus and lymph node cellularity","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined mechanistic rescue by S1PR1 overexpression; 40 citations","pmids":["24638168"],"is_preprint":false},{"year":2015,"finding":"Tyrosine 143 phosphorylation of S1PR1 is required for agonist-induced receptor internalization in endothelial cells; Y143F (phospho-defective) fails to internalize, Y143D (phospho-mimicking) shows constitutive internalization; S1PR1 dephosphorylation at Y143 accompanies receptor recycling to the plasma membrane.","method":"Site-directed mutagenesis (Y143F, Y143D), flow cytometry for surface S1PR1, TEER measurement, phospho-specific analysis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis of PTM site with multiple functional readouts","pmids":["25588843"],"is_preprint":false},{"year":2016,"finding":"S1PR1 agonism accelerates IFNAR1 turnover and suppresses STAT1 phosphorylation in plasmacytoid dendritic cells, thereby inhibiting the type I IFN autoamplification loop; this suppression is pertussis toxin-resistant but blocked by a C-terminal S1PR1 peptide that prevents receptor internalization, indicating internalization is required for the immunosuppressive mechanism.","method":"Pharmacological S1PR1 agonism and antagonism, Tat-fusion peptide blocking internalization, IFNAR1 turnover assay, pSTAT1 Western blot, in vivo CpG-A IFN-α induction","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal pharmacological tools and peptide-based mechanistic dissection with in vivo validation","pmids":["26787880"],"is_preprint":false},{"year":2016,"finding":"T cell-intrinsic S1PR1 is the master regulator of effector T cell sinus entry and egress from draining lymph nodes during infection; S1PR1-deficient effector T cells migrate normally within the paracortex but fail to enter lymphatic sinuses.","method":"Inducible T cell-specific S1PR1 knockout mice, two-photon intravital microscopy, adoptive transfer","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — inducible conditional KO with direct intravital visualization of trafficking step","pmids":["26862175"],"is_preprint":false},{"year":2013,"finding":"Moesin controls clathrin-mediated S1PR1 internalization in T cells; moesin-deficient T cells fail to form clathrin-coated vesicles and internalize S1PR1 upon S1P stimulation, resulting in delayed lymphopenia after FTY720 treatment and persistent S1P chemotaxis ex vivo.","method":"Moesin-deficient mice, FTY720 treatment, clathrin inhibitor, colocalization of S1PR1 with clathrin-coated vesicles/early endosomes, chemotaxis assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with pharmacological and mechanistic validation in vivo and ex vivo","pmids":["24358210"],"is_preprint":false},{"year":2017,"finding":"S1PR1 in tumor-associated macrophages promotes lymphangiogenesis and pulmonary metastasis via NLRP3 inflammasome activation and IL-1β production; conditional S1PR1 deletion in CD11bhi CD206+ TAMs reduces Nlrp3 expression and prevents metastasis.","method":"Myeloid-specific S1PR1 conditional knockout mice, transcriptome analysis of isolated TAMs, in vitro macrophage-lymphangiogenesis assay, inflammasome activation","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with transcriptomic and functional mechanistic follow-up","pmids":["28739604"],"is_preprint":false},{"year":2021,"finding":"Cryo-EM structures of S1PR1 and S1PR5 bound to diverse agonists and heterotrimeric Gi protein reveal: (1) distinct binding modes of chemically different agonists, (2) the mechanical switch that activates these receptors, and (3) the structural basis of G protein coupling and ligand selectivity.","method":"Cryo-electron microscopy structure determination, functional signaling assays","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 1 — multiple cryo-EM structures with orthogonal functional validation","pmids":["34526663"],"is_preprint":false},{"year":2023,"finding":"CD69 acts as a protein agonist of S1PR1 in cis: cryo-EM structure of CD69-S1PR1-Gi complex shows the CD69 transmembrane helix contacts S1PR1-TM4, allosterically inducing TM5-6 movement to activate Gi coupling and promote receptor internalization and degradation, inhibiting lymphocyte egress.","method":"Cryo-EM structure determination, mutagenesis of interface residues, S1PR1 internalization assay, lymphocyte egress assay","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure plus mutagenesis and functional validation; defines novel protein agonist mechanism","pmids":["37039481"],"is_preprint":false},{"year":2021,"finding":"Endothelial S1PR1 activates ERK signaling and upregulates CSF1 expression, promoting Ly6clow reparative macrophage proliferation via cell-contact manner, thereby ameliorating post-myocardial infarction cardiac remodeling.","method":"Endothelial-specific S1pr1 knockout mice, pharmacological S1PR1 activation, CSF1 blockade, flow cytometry, in vitro co-culture","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with pathway rescue experiment; single lab","pmids":["32091582"],"is_preprint":false},{"year":2019,"finding":"Endothelial S1PR1 activates AKT/eNOS signaling, increasing NO production which inhibits cardiomyocyte hypertrophy and cardiac fibroblast activation; endothelial-specific S1pr1 deletion aggravates pressure overload-induced cardiac dysfunction.","method":"Endothelial-specific S1pr1 conditional KO mice, transverse aortic constriction model, in vitro AKT/eNOS pathway inhibition, NO measurement","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined pathway rescue; single lab","pmids":["31854513"],"is_preprint":false},{"year":2014,"finding":"Hypothalamic S1PR1 in POMC neurons activates STAT3 and the melanocortin system to reduce food intake and increase energy expenditure; STAT3 in turn upregulates S1PR1 expression in a positive feedback loop; selective disruption of hypothalamic S1PR1 increases food intake.","method":"Intracerebroventricular S1P injection, selective hypothalamic S1PR1 disruption, STAT3 phosphorylation assay, food intake and energy expenditure measurement in rodents","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo gain/loss-of-function with mechanistic pathway definition; single lab","pmids":["25255053"],"is_preprint":false},{"year":2016,"finding":"miR302-367 reduces Erk1/2 in endothelial cells, which increases KLF2 expression, which in turn upregulates S1PR1 and VE-cadherin; genetic or pharmacological S1PR1 deletion reverses the anti-angiogenic and vascular-stabilizing effects of miR302-367.","method":"Endothelial-specific miR302-367 overexpression, S1PR1 conditional KO mice, pharmacological S1PR1 blockade, in vitro and in vivo angiogenesis assays","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via genetic KO rescue plus in vitro validation; single lab","pmids":["27756792"],"is_preprint":false},{"year":2021,"finding":"aPC activates PAR1 to recruit β-arrestin-2, which activates SphK1 independent of Dvl2; SphK1 then transactivates S1PR1 to activate Akt and protect endothelial cells from apoptosis. S1PR1 co-associates with caveolin-1, and aPC increases S1PR1/Cav1 association; this pathway is distinct from the PAR1-β-arr2-ERK1/2 pathway.","method":"siRNA knockdown of PAR1, S1PR1, SphK1, β-arrestin-2, Cav1; co-immunoprecipitation; apoptosis assay in human endothelial cells","journal":"Proceedings of the National Academy of Sciences","confidence":"Medium","confidence_rationale":"Tier 2 — multiple siRNA knockdowns with co-IP and functional apoptosis readout; single lab","pmids":["34873055"],"is_preprint":false},{"year":2024,"finding":"S1PR1 limits T cell apoptosis by maintaining BCL2 family balance via restraint of JNK activity; the same C-terminal residues required for receptor internalization are necessary for this anti-apoptotic function, linking internalization to survival signaling.","method":"S1PR1 internalization-defective mutants, JNK activity assay, BCL2 family protein expression, apoptosis assay, validation in ozanimod-treated ulcerative colitis patients","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis linking internalization to anti-apoptotic signaling with clinical translational validation","pmids":["38194271"],"is_preprint":false},{"year":2023,"finding":"S1PR1 (ortholog of Drosophila Tre1) is required for astrocyte process elaboration; loss of s1pr1 in zebrafish disrupts astrocyte process extension/retraction dynamics during growth, leading to defects in motor behavior.","method":"s1pr1 zebrafish knockout, live imaging of astrocyte process dynamics, pharmacological treatment, Drosophila Tre1 mutant analysis","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO in zebrafish ortholog model with live imaging; evolutionarily conserved function","pmids":["38096817"],"is_preprint":false},{"year":2020,"finding":"STAT1 transcription factor binds to the -29 to -12 bp minimal promoter region of S1PR1, directly stimulating S1PR1 expression; STAT1 knockdown reduces S1PR1 and overexpression or IFN-γ activation of STAT1 increases S1PR1 levels.","method":"EMSA, ChIP assay, promoter-reporter truncation analysis, STAT1 siRNA knockdown, IFN-γ stimulation","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 1–2 — EMSA and ChIP with functional promoter mapping; single lab","pmids":["32006593"],"is_preprint":false},{"year":2012,"finding":"CCR7/CCL19 signaling upregulates EDG-1/S1PR1 expression in T cells via an ERK5-KLF2 pathway; ERK5 conditional deletion in T cells abolishes CCL19-stimulated S1PR1 upregulation and migration toward S1P.","method":"ERK5flox/flox/Lck-Cre conditional KO mice, human T cell line CCR7 stimulation, KLF2 and S1PR1 expression analysis, chemotaxis assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with defined pathway; single lab","pmids":["22334704"],"is_preprint":false},{"year":2012,"finding":"IL-10 stimulation induces S1PR1 expression in lymph node T cells via STAT3-dependent signaling, promoting CD4+ T cell egress and peripheral nerve infiltration in autoimmune neuropathy.","method":"IL-10-deficient mice, IL-10 in vitro stimulation of lymph node cells, STAT3 inhibition, S1PR1 expression analysis, histological nerve infiltration assessment","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — IL-10 KO mouse model with in vitro pathway dissection; single lab","pmids":["29367208"],"is_preprint":false},{"year":2022,"finding":"S1PR1/S1P/Sphk1 pathway differentially modulates CD4+ vs. CD8+ T cell alloreactivity by augmenting mitochondrial fission and increasing mitochondrial mass specifically in allogeneic CD4+ T cells via AMPK/AKT/mTOR/Drp1 signaling.","method":"Sphk1 and S1PR1 conditional knockouts, pharmacological inhibitors, GVHD mouse model, mitochondrial mass and fission assays, flow cytometry","journal":"Cellular & molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacologic loss-of-function with mechanistic pathway readout; single lab","pmids":["36071219"],"is_preprint":false}],"current_model":"S1PR1 (EDG-1) is a Gi-coupled GPCR for sphingosine-1-phosphate whose ligand-binding pocket is defined by Arg120, Arg292, and Glu121; upon S1P binding it activates Rac (via PI3K), MAPK, and AKT/eNOS while inhibiting adenylate cyclase, and undergoes GRK2- and Tyr143-phosphorylation-dependent clathrin/dynamin-2-mediated internalization (facilitated by moesin and N-glycosylation at Asn30) that is essential for lymphocyte egress from lymphoid organs, vascular maturation, thrombopoiesis, and energy homeostasis; its expression is transcriptionally driven by KLF2, STAT1, STAT3, and CCR7/ERK5/KLF2, and reciprocally S1PR1 sustains persistent STAT3 activation via JAK2 upregulation, forming a positive feedback loop that promotes tumor progression; additionally, CD69 acts as a protein agonist of S1PR1 by contacting TM4 to allosterically activate Gi coupling and promote receptor internalization."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that EDG-1 is a bona fide Gi/o-coupled S1P receptor resolved the orphan receptor's identity and defined its core signaling repertoire (PLC, Ca²⁺, MAPK, adenylate cyclase inhibition).","evidence":"Reconstitution in CHO/HEL cells with radioligand binding, pertussis toxin sensitivity, and multiple second-messenger assays","pmids":["9765227"],"confidence":"High","gaps":["Downstream effectors beyond PLC/MAPK not yet mapped","In vivo relevance of S1PR1 signaling unknown"]},{"year":1999,"claim":"Demonstrating exclusive Gi coupling (versus Gq for EDG-3/EDG-5) and agonist-induced internalization with C-terminal dependence established the receptor's subtype-specific G-protein selectivity and trafficking behavior.","evidence":"Xenopus oocyte chimeric Gα reconstitution for coupling specificity; GFP-tagged receptor live imaging and C-terminal truncation in HEK293 for internalization","pmids":["10383399","10198065"],"confidence":"High","gaps":["Kinase(s) mediating C-terminal phosphorylation unknown","Endosomal fate and recycling mechanism not defined"]},{"year":2000,"claim":"Knockout mice and mutagenesis revealed that S1PR1 mediates Rac activation via PI3K to drive cell migration and vascular maturation, and identified Arg120/Arg292/Glu121 as the ligand-binding triad, connecting receptor structure to developmental phenotype.","evidence":"Edg1−/− mouse embryonic cells (Rac/migration defects, vascular smooth muscle loss); site-directed mutagenesis with radioligand and GTPγS binding; reconstitution in CHO cells for PI3K-Rac-chemotaxis axis","pmids":["11032855","10982820","11094076"],"confidence":"High","gaps":["Structural basis of Gi engagement not yet visualized","Tissue-specific roles beyond vasculature unexplored"]},{"year":2001,"claim":"Identification of GRK2 as the kinase driving agonist-induced internalization (distinct from PKC-mediated phosphorylation) and a single-residue determinant of S1P versus LPA selectivity established the mechanistic basis for receptor desensitization and ligand discrimination.","evidence":"In vitro GRK2 kinase assay and C-terminal truncation mutants; Glu/Gln interchange mutagenesis between S1P1 and LPA1","pmids":["11741892","11604399"],"confidence":"High","gaps":["In vivo consequence of GRK2-dependent desensitization for lymphocyte trafficking not yet tested","Complete phosphorylation site map lacking"]},{"year":2002,"claim":"N-glycosylation at Asn30 was shown to be required for ligand-induced internalization and caveolar localization but dispensable for ligand binding and MAPK signaling, dissociating surface signaling from endocytic trafficking.","evidence":"N30D mutagenesis with sucrose gradient fractionation, internalization, binding, and MAPK assays","pmids":["12087059"],"confidence":"High","gaps":["Role of caveolar versus clathrin-mediated endocytosis not resolved","Glycosylation impact on in vivo receptor function untested"]},{"year":2010,"claim":"Discovery of the S1PR1-STAT3 positive feedback loop — STAT3 transcribes S1PR1, and S1PR1 reciprocally sustains STAT3 via JAK2 upregulation — provided a mechanistic basis for persistent oncogenic STAT3 activation.","evidence":"ChIP for STAT3 on S1PR1 promoter, siRNA, reporter assays, JAK2/pSTAT3 Western blots, tumor xenografts","pmids":["21102457"],"confidence":"High","gaps":["How S1PR1 upregulates JAK2 at the molecular level unclear","Whether feedback loop operates in all tumor types unknown"]},{"year":2011,"claim":"Genetic epistasis in conditional GRK2-knockout mice proved that GRK2-mediated S1PR1 desensitization on blood-exposed lymphocytes is required for lymphocyte entry into lymphoid tissues, connecting receptor desensitization to immune cell trafficking in vivo.","evidence":"Conditional GRK2 KO mice, adoptive transfer, rescue in S1P-deficient background, desensitization motif point mutant","pmids":["21960637"],"confidence":"High","gaps":["Phosphorylation site specificity for desensitization versus internalization not resolved","Whether other GRKs contribute in vivo not excluded"]},{"year":2012,"claim":"Multiple conditional knockout studies expanded S1PR1's physiological roles to megakaryocyte-directed thrombopoiesis, endothelial vascular integrity (downstream of Smad2/3), and T cell trafficking regulated by CCR7-ERK5-KLF2 transcriptional control of S1PR1 expression.","evidence":"Megakaryocyte-specific S1PR1 KO with intravital imaging (thrombocytopenia); endothelial Smad2/3 double KO with reduced S1PR1; ERK5-conditional KO in T cells abolishing CCL19-stimulated S1PR1 upregulation","pmids":["23148237","22498737","22334704"],"confidence":"High","gaps":["Signaling intermediates linking S1PR1 to proplatelet extension not mapped","Direct Smad2/3 binding to S1PR1 promoter not shown"]},{"year":2013,"claim":"KLF2 was identified as the key transcription factor driving S1PR1 expression in T cells, with TGF-β/IL-33/TNF suppressing KLF2 via PI3K/Akt to downregulate S1PR1, thereby enabling tissue-resident memory T cell formation; separately, moesin was shown to be required for clathrin-mediated S1PR1 internalization.","evidence":"Retroviral forced S1PR1 expression preventing TRM formation; moesin-KO mice with impaired clathrin-coated vesicle formation and S1PR1 internalization","pmids":["24162775","24358210"],"confidence":"High","gaps":["Direct moesin-S1PR1 physical interaction not demonstrated","How moesin specifically enables clathrin coat assembly on S1PR1 unclear"]},{"year":2014,"claim":"Dynamin-2-dependent endocytosis was shown to sustain S1PR1 signaling at low S1P concentrations near lymphoid exit sites, establishing that endosomal signaling (not just surface signaling) is required for lymphocyte egress.","evidence":"T cell-specific dynamin-2 KO mice with defective egress rescued by S1PR1 overexpression","pmids":["24638168"],"confidence":"High","gaps":["Endosomal signaling effectors downstream of internalized S1PR1 not identified","Whether signaling endosomes carry Gi or switch to other effectors unknown"]},{"year":2015,"claim":"Tyr143 phosphorylation was identified as a required step for agonist-induced S1PR1 internalization, with phospho-mimetic (Y143D) causing constitutive internalization and phospho-dead (Y143F) blocking it, adding a tyrosine phosphorylation checkpoint to the GRK2/serine-threonine mechanism.","evidence":"Y143F/Y143D mutagenesis with flow cytometry and TEER in endothelial cells","pmids":["25588843"],"confidence":"High","gaps":["Kinase phosphorylating Y143 not identified","Relationship between Y143 phosphorylation and GRK2-mediated C-terminal phosphorylation unresolved"]},{"year":2016,"claim":"S1PR1 internalization was shown to suppress type I IFN signaling by accelerating IFNAR1 turnover independently of Gi (pertussis toxin-resistant), revealing an internalization-dependent immunomodulatory mechanism; simultaneously, KLF2-dependent S1PR1 expression downstream of miR302-367/ERK was linked to vascular stabilization.","evidence":"S1PR1 agonism with Tat-fusion peptide blocking internalization in pDCs; miR302-367 OE with S1PR1 conditional KO epistasis","pmids":["26787880","27756792"],"confidence":"High","gaps":["Mechanism by which internalized S1PR1 promotes IFNAR1 degradation unknown","Whether miR302-367-KLF2-S1PR1 axis operates outside developmental angiogenesis unclear"]},{"year":2021,"claim":"Cryo-EM structures of S1PR1-Gi complexes provided atomic-level visualization of the ligand-binding pocket, the activation switch (TM5-6 rearrangement), and the Gi-coupling interface, validating decades of mutagenesis data; additionally, the S1PR1-STAT3 loop was extended to hypothalamic energy homeostasis and endothelial cardioprotection.","evidence":"Cryo-EM structures with diverse agonists; hypothalamic S1PR1 disruption altering food intake via STAT3; endothelial S1PR1-KO exacerbating cardiac remodeling with CSF1/macrophage and AKT/eNOS readouts","pmids":["34526663","25255053","32091582","31854513"],"confidence":"High","gaps":["Dynamics of receptor activation in membrane environment not captured","How S1PR1-STAT3 loop integrates with canonical JAK-STAT kinetics in neurons versus tumor cells unclear"]},{"year":2023,"claim":"CD69 was revealed as an unprecedented protein agonist of S1PR1: its TM helix contacts S1PR1-TM4 to allosterically activate Gi and drive internalization/degradation, providing the structural mechanism for CD69-mediated lymphocyte retention in tissues.","evidence":"Cryo-EM structure of CD69-S1PR1-Gi complex, interface mutagenesis, internalization and egress assays","pmids":["37039481"],"confidence":"High","gaps":["Whether other transmembrane proteins use a similar TM-contact agonism mechanism unknown","In vivo stoichiometry and regulation of CD69-S1PR1 interaction not defined"]},{"year":2024,"claim":"S1PR1 internalization was linked to T cell survival via BCL2 family balance and JNK restraint, with the same C-terminal residues required for internalization also necessary for anti-apoptotic function, unifying trafficking and survival signaling.","evidence":"Internalization-defective mutants, JNK/BCL2 assays, validation in ozanimod-treated ulcerative colitis patients","pmids":["38194271"],"confidence":"Medium","gaps":["Direct endosomal signaling intermediates linking internalized S1PR1 to JNK suppression not identified","Whether anti-apoptotic function is Gi-dependent or Gi-independent not resolved"]},{"year":null,"claim":"Key unresolved questions include the identity of the kinase phosphorylating Tyr143, the precise endosomal signaling complex composition after S1PR1 internalization, and whether the CD69 protein-agonist paradigm extends to other GPCRs.","evidence":"","pmids":[],"confidence":"Low","gaps":["Y143 kinase identity unknown","Endosomal signaling effectors of internalized S1PR1 not characterized","Structural basis of S1PR1-JAK2 upregulation mechanism undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,23,24]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,9,18]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2,21]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[2,17]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,4,8,10,23,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[11,15,17,20,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,13,28]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[10,14,22]}],"complexes":[],"partners":["GRK2","STAT3","CD69","KLF2","MSN","DNM2","SPHK1"],"other_free_text":[]},"mechanistic_narrative":"S1PR1 is a Gi-coupled GPCR for sphingosine-1-phosphate that orchestrates lymphocyte trafficking, vascular maturation, endothelial barrier function, and immune regulation by coupling extracellular S1P gradients to intracellular PI3K/Rac, MAPK, AKT/eNOS, and JAK2/STAT3 signaling cascades [PMID:9765227, PMID:11032855, PMID:21102457, PMID:31854513]. Ligand recognition depends on Arg120 and Arg292 (ion-pairing with the S1P phosphate head group) and Glu121 (contacting the ammonium group), as confirmed by mutagenesis and cryo-EM structures that further revealed the mechanical activation switch and Gi-coupling interface [PMID:10982820, PMID:34526663]. Agonist-induced internalization requires GRK2-mediated C-terminal phosphorylation, Tyr143 phosphorylation, moesin-dependent clathrin-coated vesicle formation, and dynamin-2-dependent endocytosis; this internalization is essential for lymphocyte egress from lymphoid organs, T cell survival via BCL2/JNK regulation, and suppression of type I interferon signaling [PMID:11741892, PMID:25588843, PMID:24358210, PMID:24638168, PMID:38194271, PMID:26787880]. S1PR1 expression is transcriptionally driven by KLF2, STAT1, and STAT3, while CD69 functions as an unconventional protein agonist that contacts TM4 to allosterically activate Gi coupling and trigger receptor downregulation, thereby blocking lymphocyte egress [PMID:24162775, PMID:32006593, PMID:21102457, PMID:37039481]."},"prefetch_data":{"uniprot":{"accession":"P21453","full_name":"Sphingosine 1-phosphate receptor 1","aliases":["Endothelial differentiation G-protein coupled receptor 1","Sphingosine 1-phosphate receptor Edg-1","S1P receptor Edg-1"],"length_aa":382,"mass_kda":42.8,"function":"G-protein coupled receptor for the bioactive lysosphingolipid sphingosine 1-phosphate (S1P) that seems to be coupled to the G(i) subclass of heteromeric G proteins. Signaling leads to the activation of RAC1, SRC, PTK2/FAK1 and MAP kinases. Plays an important role in cell migration, probably via its role in the reorganization of the actin cytoskeleton and the formation of lamellipodia in response to stimuli that increase the activity of the sphingosine kinase SPHK1. Required for normal chemotaxis toward sphingosine 1-phosphate. Required for normal embryonic heart development and normal cardiac morphogenesis. Plays an important role in the regulation of sprouting angiogenesis and vascular maturation. Inhibits sprouting angiogenesis to prevent excessive sprouting during blood vessel development. Required for normal egress of mature T-cells from the thymus into the blood stream and into peripheral lymphoid organs. Plays a role in the migration of osteoclast precursor cells, the regulation of bone mineralization and bone homeostasis (By similarity). Plays a role in responses to oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine by pulmonary endothelial cells and in the protection against ventilator-induced lung injury","subcellular_location":"Cell membrane; Endosome; Membrane raft","url":"https://www.uniprot.org/uniprotkb/P21453/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/S1PR1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/S1PR1","total_profiled":1310},"omim":[{"mim_id":"613492","title":"ALKALINE CERAMIDASE 2; ACER2","url":"https://www.omim.org/entry/613492"},{"mim_id":"612584","title":"SPHINGOLIPID TRANSPORTER 2; SPNS2","url":"https://www.omim.org/entry/612584"},{"mim_id":"608863","title":"PODOPLANIN; PDPN","url":"https://www.omim.org/entry/608863"},{"mim_id":"607092","title":"SPHINGOSINE KINASE 2; SPHK2","url":"https://www.omim.org/entry/607092"},{"mim_id":"606783","title":"C-TYPE LECTIN DOMAIN FAMILY 1, MEMBER B; CLEC1B","url":"https://www.omim.org/entry/606783"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/S1PR1"},"hgnc":{"alias_symbol":["edg-1","D1S3362","CD363"],"prev_symbol":["EDG1"]},"alphafold":{"accession":"P21453","domains":[{"cath_id":"1.20.1070.10","chopping":"31-330","consensus_level":"high","plddt":88.8441,"start":31,"end":330}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21453","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21453-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21453-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=S1PR1","jax_strain_url":"https://www.jax.org/strain/search?query=S1PR1"},"sequence":{"accession":"P21453","fasta_url":"https://rest.uniprot.org/uniprotkb/P21453.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21453/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21453"}},"corpus_meta":[{"pmid":"11032855","id":"PMC_11032855","title":"Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11032855","citation_count":977,"is_preprint":false},{"pmid":"24162775","id":"PMC_24162775","title":"Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells.","date":"2013","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24162775","citation_count":680,"is_preprint":false},{"pmid":"21102457","id":"PMC_21102457","title":"STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.","date":"2010","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21102457","citation_count":339,"is_preprint":false},{"pmid":"11094076","id":"PMC_11094076","title":"Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11094076","citation_count":275,"is_preprint":false},{"pmid":"9765227","id":"PMC_9765227","title":"EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9765227","citation_count":245,"is_preprint":false},{"pmid":"28739604","id":"PMC_28739604","title":"S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28739604","citation_count":236,"is_preprint":false},{"pmid":"10383399","id":"PMC_10383399","title":"Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10383399","citation_count":225,"is_preprint":false},{"pmid":"22624714","id":"PMC_22624714","title":"S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.","date":"2012","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/22624714","citation_count":209,"is_preprint":false},{"pmid":"29351902","id":"PMC_29351902","title":"Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29351902","citation_count":187,"is_preprint":false},{"pmid":"21960637","id":"PMC_21960637","title":"GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood.","date":"2011","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/21960637","citation_count":170,"is_preprint":false},{"pmid":"10198065","id":"PMC_10198065","title":"Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1.","date":"1999","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10198065","citation_count":169,"is_preprint":false},{"pmid":"10381367","id":"PMC_10381367","title":"EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10381367","citation_count":142,"is_preprint":false},{"pmid":"10982820","id":"PMC_10982820","title":"Identification of Edg1 receptor residues that recognize sphingosine 1-phosphate.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10982820","citation_count":133,"is_preprint":false},{"pmid":"23148237","id":"PMC_23148237","title":"A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis.","date":"2012","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23148237","citation_count":126,"is_preprint":false},{"pmid":"26856814","id":"PMC_26856814","title":"The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.","date":"2016","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26856814","citation_count":103,"is_preprint":false},{"pmid":"11604399","id":"PMC_11604399","title":"A single amino acid determines lysophospholipid specificity of the S1P1 (EDG1) and LPA1 (EDG2) phospholipid growth factor receptors.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11604399","citation_count":89,"is_preprint":false},{"pmid":"22098666","id":"PMC_22098666","title":"Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.","date":"2011","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/22098666","citation_count":89,"is_preprint":false},{"pmid":"11549339","id":"PMC_11549339","title":"EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes.","date":"2001","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/11549339","citation_count":83,"is_preprint":false},{"pmid":"25911753","id":"PMC_25911753","title":"miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr/lpr Mice.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25911753","citation_count":80,"is_preprint":false},{"pmid":"22745305","id":"PMC_22745305","title":"S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22745305","citation_count":78,"is_preprint":false},{"pmid":"11741892","id":"PMC_11741892","title":"Dual regulation of EDG1/S1P(1) receptor phosphorylation and internalization by protein kinase C and G-protein-coupled receptor kinase 2.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11741892","citation_count":76,"is_preprint":false},{"pmid":"30451830","id":"PMC_30451830","title":"Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/30451830","citation_count":71,"is_preprint":false},{"pmid":"37251708","id":"PMC_37251708","title":"Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway.","date":"2023","source":"Burns & trauma","url":"https://pubmed.ncbi.nlm.nih.gov/37251708","citation_count":69,"is_preprint":false},{"pmid":"11673450","id":"PMC_11673450","title":"Sphingosine 1-phosphate activates nuclear factor-kappa B through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11673450","citation_count":69,"is_preprint":false},{"pmid":"24631531","id":"PMC_24631531","title":"MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells.","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/24631531","citation_count":66,"is_preprint":false},{"pmid":"34526663","id":"PMC_34526663","title":"Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition.","date":"2021","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34526663","citation_count":65,"is_preprint":false},{"pmid":"12087059","id":"PMC_12087059","title":"N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12087059","citation_count":65,"is_preprint":false},{"pmid":"9226368","id":"PMC_9226368","title":"The mouse gene for the inducible G-protein-coupled receptor edg-1.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9226368","citation_count":65,"is_preprint":false},{"pmid":"26862175","id":"PMC_26862175","title":"T cell-intrinsic S1PR1 regulates endogenous effector T-cell egress dynamics from lymph nodes during infection.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26862175","citation_count":64,"is_preprint":false},{"pmid":"25255053","id":"PMC_25255053","title":"Hypothalamic S1P/S1PR1 axis controls energy homeostasis.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25255053","citation_count":61,"is_preprint":false},{"pmid":"30083262","id":"PMC_30083262","title":"Targeting S1PR1/STAT3 loop abrogates desmoplasia and chemosensitizes pancreatic cancer to gemcitabine.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/30083262","citation_count":61,"is_preprint":false},{"pmid":"28570482","id":"PMC_28570482","title":"Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation.","date":"2017","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/28570482","citation_count":61,"is_preprint":false},{"pmid":"22498737","id":"PMC_22498737","title":"Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22498737","citation_count":61,"is_preprint":false},{"pmid":"31534132","id":"PMC_31534132","title":"The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31534132","citation_count":60,"is_preprint":false},{"pmid":"31115798","id":"PMC_31115798","title":"S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.","date":"2019","source":"Molecular diagnosis & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31115798","citation_count":58,"is_preprint":false},{"pmid":"10818441","id":"PMC_10818441","title":"Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10818441","citation_count":56,"is_preprint":false},{"pmid":"23554499","id":"PMC_23554499","title":"An activated protein C analog stimulates neuronal production by human neural progenitor cells via a PAR1-PAR3-S1PR1-Akt pathway.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23554499","citation_count":55,"is_preprint":false},{"pmid":"30377291","id":"PMC_30377291","title":"Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30377291","citation_count":55,"is_preprint":false},{"pmid":"26787880","id":"PMC_26787880","title":"S1PR1-mediated IFNAR1 degradation modulates plasmacytoid dendritic cell interferon-α autoamplification.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26787880","citation_count":54,"is_preprint":false},{"pmid":"29377379","id":"PMC_29377379","title":"SPHK1-S1PR1-RANKL Axis Regulates the Interactions Between Macrophages and BMSCs in Inflammatory Bone Loss.","date":"2018","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/29377379","citation_count":52,"is_preprint":false},{"pmid":"32091582","id":"PMC_32091582","title":"Vascular endothelial S1pr1 ameliorates adverse cardiac remodelling via stimulating reparative macrophage proliferation after myocardial infarction.","date":"2021","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/32091582","citation_count":50,"is_preprint":false},{"pmid":"26975859","id":"PMC_26975859","title":"PET Imaging Study of S1PR1 Expression in a Rat Model of Multiple Sclerosis.","date":"2016","source":"Molecular imaging and biology","url":"https://pubmed.ncbi.nlm.nih.gov/26975859","citation_count":49,"is_preprint":false},{"pmid":"19036707","id":"PMC_19036707","title":"beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.","date":"2008","source":"Journal of biomolecular screening","url":"https://pubmed.ncbi.nlm.nih.gov/19036707","citation_count":45,"is_preprint":false},{"pmid":"20844107","id":"PMC_20844107","title":"The sphingosine 1-phosphate receptor, S1PR₁, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons.","date":"2010","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/20844107","citation_count":45,"is_preprint":false},{"pmid":"10818438","id":"PMC_10818438","title":"Sphingosine-1-phosphate signaling via the EDG-1 family of G-protein-coupled receptors.","date":"2000","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/10818438","citation_count":42,"is_preprint":false},{"pmid":"27756792","id":"PMC_27756792","title":"A MicroRNA302-367-Erk1/2-Klf2-S1pr1 Pathway Prevents Tumor Growth via Restricting Angiogenesis and Improving Vascular Stability.","date":"2016","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/27756792","citation_count":41,"is_preprint":false},{"pmid":"31854513","id":"PMC_31854513","title":"Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31854513","citation_count":40,"is_preprint":false},{"pmid":"24638168","id":"PMC_24638168","title":"Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling.","date":"2014","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24638168","citation_count":40,"is_preprint":false},{"pmid":"36068200","id":"PMC_36068200","title":"S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36068200","citation_count":36,"is_preprint":false},{"pmid":"23212923","id":"PMC_23212923","title":"Critical role of S1PR1 and integrin β4 in HGF/c-Met-mediated increases in vascular integrity.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23212923","citation_count":36,"is_preprint":false},{"pmid":"31293578","id":"PMC_31293578","title":"S1P-S1PR1 Signaling: the \"Sphinx\" in Osteoimmunology.","date":"2019","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31293578","citation_count":34,"is_preprint":false},{"pmid":"29608575","id":"PMC_29608575","title":"Ozanimod (RPC1063), a selective S1PR1 and S1PR5 modulator, reduces chronic inflammation and alleviates kidney pathology in murine systemic lupus erythematosus.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29608575","citation_count":34,"is_preprint":false},{"pmid":"30476824","id":"PMC_30476824","title":"S1P promotes inflammation-induced tube formation by HLECs via the S1PR1/NF-κB pathway.","date":"2018","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30476824","citation_count":33,"is_preprint":false},{"pmid":"22445889","id":"PMC_22445889","title":"Knockdown of the sphingosine-1-phosphate receptor S1PR1 reduces pain behaviors induced by local inflammation of the rat sensory ganglion.","date":"2012","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/22445889","citation_count":31,"is_preprint":false},{"pmid":"32585303","id":"PMC_32585303","title":"Post-translational modifications of S1PR1 and endothelial barrier regulation.","date":"2020","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/32585303","citation_count":29,"is_preprint":false},{"pmid":"28466272","id":"PMC_28466272","title":"bFGF Protects Against Oxygen Glucose Deprivation/Reoxygenation-Induced Endothelial Monolayer Permeability via S1PR1-Dependent Mechanisms.","date":"2017","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/28466272","citation_count":29,"is_preprint":false},{"pmid":"34113619","id":"PMC_34113619","title":"The CAGE-MiR-181b-5p-S1PR1 Axis Regulates Anticancer Drug Resistance and Autophagy in Gastric Cancer Cells.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34113619","citation_count":29,"is_preprint":false},{"pmid":"36071219","id":"PMC_36071219","title":"S1P/S1PR1 signaling differentially regulates the allogeneic response of CD4 and CD8 T cells by modulating mitochondrial fission.","date":"2022","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36071219","citation_count":28,"is_preprint":false},{"pmid":"32562552","id":"PMC_32562552","title":"Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.","date":"2020","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32562552","citation_count":28,"is_preprint":false},{"pmid":"37039481","id":"PMC_37039481","title":"Transmembrane protein CD69 acts as an S1PR1 agonist.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37039481","citation_count":26,"is_preprint":false},{"pmid":"22334704","id":"PMC_22334704","title":"CCR7/CCL19 controls expression of EDG-1 in T cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22334704","citation_count":26,"is_preprint":false},{"pmid":"34873055","id":"PMC_34873055","title":"aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete, β-arrestin-2-mediated SphK1-S1PR1-Akt signaling axis.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34873055","citation_count":26,"is_preprint":false},{"pmid":"25188412","id":"PMC_25188412","title":"Sphingosine-1-phosphate promotes extravillous trophoblast cell invasion by activating MEK/ERK/MMP-2 signaling pathways via S1P/S1PR1 axis activation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25188412","citation_count":26,"is_preprint":false},{"pmid":"25588843","id":"PMC_25588843","title":"S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25588843","citation_count":26,"is_preprint":false},{"pmid":"30316864","id":"PMC_30316864","title":"S1PR1 predicts patient survival and promotes chemotherapy drug resistance in gastric cancer cells through STAT3 constitutive activation.","date":"2018","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/30316864","citation_count":26,"is_preprint":false},{"pmid":"34109517","id":"PMC_34109517","title":"Blocking SphK1/S1P/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice.","date":"2021","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/34109517","citation_count":25,"is_preprint":false},{"pmid":"32602083","id":"PMC_32602083","title":"In vivo Characterization of Four 18F-Labeled S1PR1 Tracers for Neuroinflammation.","date":"2020","source":"Molecular imaging and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32602083","citation_count":24,"is_preprint":false},{"pmid":"24740542","id":"PMC_24740542","title":"Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth.","date":"2014","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24740542","citation_count":24,"is_preprint":false},{"pmid":"28878352","id":"PMC_28878352","title":"S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells.","date":"2017","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/28878352","citation_count":24,"is_preprint":false},{"pmid":"33101013","id":"PMC_33101013","title":"Coix Seed Oil Exerts an Anti-Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33101013","citation_count":24,"is_preprint":false},{"pmid":"37012886","id":"PMC_37012886","title":"Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37012886","citation_count":23,"is_preprint":false},{"pmid":"34301921","id":"PMC_34301921","title":"SMYD3 promotes hepatocellular carcinoma progression by methylating S1PR1 promoters.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34301921","citation_count":22,"is_preprint":false},{"pmid":"32424937","id":"PMC_32424937","title":"Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32424937","citation_count":22,"is_preprint":false},{"pmid":"29604582","id":"PMC_29604582","title":"Syntheses and in vitro evaluation of new S1PR1 compounds and initial evaluation of a lead F-18 radiotracer in rodents.","date":"2018","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29604582","citation_count":22,"is_preprint":false},{"pmid":"30082521","id":"PMC_30082521","title":"MiR-125b-1-3p Exerts Antitumor Functions in Lung Carcinoma Cells by Targeting S1PR1.","date":"2018","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/30082521","citation_count":22,"is_preprint":false},{"pmid":"22504650","id":"PMC_22504650","title":"B cell-specific S1PR1 deficiency blocks prion dissemination between secondary lymphoid organs.","date":"2012","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/22504650","citation_count":22,"is_preprint":false},{"pmid":"36204852","id":"PMC_36204852","title":"Siponimod exerts neuroprotective effects on the retina and higher visual pathway through neuronal S1PR1 in experimental glaucoma.","date":"2023","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/36204852","citation_count":21,"is_preprint":false},{"pmid":"32753631","id":"PMC_32753631","title":"LncRNA KCNQ1OT1 regulates the invasion and migration of hepatocellular carcinoma by acting on S1PR1 through miR-149.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32753631","citation_count":21,"is_preprint":false},{"pmid":"38194271","id":"PMC_38194271","title":"S1PR1 inhibition induces proapoptotic signaling in T cells and limits humoral responses within lymph nodes.","date":"2024","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38194271","citation_count":20,"is_preprint":false},{"pmid":"38823539","id":"PMC_38823539","title":"Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1/S1P/S1PR1/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier.","date":"2024","source":"Chemico-biological interactions","url":"https://pubmed.ncbi.nlm.nih.gov/38823539","citation_count":20,"is_preprint":false},{"pmid":"24358210","id":"PMC_24358210","title":"Moesin controls clathrin-mediated S1PR1 internalization in T cells.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24358210","citation_count":20,"is_preprint":false},{"pmid":"37030556","id":"PMC_37030556","title":"Study on the action mechanism of Buyang Huanwu Decoction against ischemic stroke based on S1P/S1PR1/PI3K/Akt signaling pathway.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37030556","citation_count":20,"is_preprint":false},{"pmid":"28039439","id":"PMC_28039439","title":"Hypothalamic S1P/S1PR1 axis controls energy homeostasis in Middle-Aged Rodents: the reversal effects of physical exercise.","date":"2016","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/28039439","citation_count":20,"is_preprint":false},{"pmid":"31357710","id":"PMC_31357710","title":"Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation.","date":"2019","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31357710","citation_count":19,"is_preprint":false},{"pmid":"37699301","id":"PMC_37699301","title":"Aralia saponin A isolated from Achyranthes bidentata Bl. ameliorates LPS/D-GalN induced acute liver injury via SPHK1/S1P/S1PR1 pathway in vivo and in vitro.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37699301","citation_count":19,"is_preprint":false},{"pmid":"30712389","id":"PMC_30712389","title":"Potential involvement of S1PR1/STAT3 signaling pathway in cardiac valve damage due to rheumatic heart disease.","date":"2019","source":"Biotechnic & histochemistry : official publication of the Biological Stain Commission","url":"https://pubmed.ncbi.nlm.nih.gov/30712389","citation_count":19,"is_preprint":false},{"pmid":"30963819","id":"PMC_30963819","title":"Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2h4 Mice.","date":"2019","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/30963819","citation_count":19,"is_preprint":false},{"pmid":"36714534","id":"PMC_36714534","title":"Inhibitory Effect of Astragalus Polysaccharide on Premetastatic Niche of Lung Cancer through the S1PR1-STAT3 Signaling Pathway.","date":"2023","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/36714534","citation_count":19,"is_preprint":false},{"pmid":"33057139","id":"PMC_33057139","title":"BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33057139","citation_count":19,"is_preprint":false},{"pmid":"38096817","id":"PMC_38096817","title":"Astrocyte growth is driven by the Tre1/S1pr1 phospholipid-binding G protein-coupled receptor.","date":"2023","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/38096817","citation_count":18,"is_preprint":false},{"pmid":"37735908","id":"PMC_37735908","title":"Force-Loaded Cementocytes Regulate Osteoclastogenesis via S1P/S1PR1/Rac1 Axis.","date":"2023","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/37735908","citation_count":18,"is_preprint":false},{"pmid":"29367208","id":"PMC_29367208","title":"IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.","date":"2018","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/29367208","citation_count":18,"is_preprint":false},{"pmid":"37828220","id":"PMC_37828220","title":"S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway.","date":"2023","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/37828220","citation_count":17,"is_preprint":false},{"pmid":"36600310","id":"PMC_36600310","title":"S1PR1/S1PR3-YAP signaling and S1P-ALOX15 signaling contribute to an aggressive behavior in obesity-lymphoma.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/36600310","citation_count":17,"is_preprint":false},{"pmid":"30462126","id":"PMC_30462126","title":"Syntheses and in vitro biological evaluation of S1PR1 ligands and PET studies of four F-18 labeled radiotracers in the brain of nonhuman primates.","date":"2018","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30462126","citation_count":17,"is_preprint":false},{"pmid":"38101611","id":"PMC_38101611","title":"Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.","date":"2023","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/38101611","citation_count":17,"is_preprint":false},{"pmid":"32006593","id":"PMC_32006593","title":"STAT1 transcriptionally regulates the expression of S1PR1 by binding its promoter region.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/32006593","citation_count":16,"is_preprint":false},{"pmid":"33715582","id":"PMC_33715582","title":"miR-145-5p exerts anti-tumor effects in diffuse large B-cell lymphoma by regulating S1PR1/STAT3/AKT pathway.","date":"2021","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/33715582","citation_count":16,"is_preprint":false},{"pmid":"27073467","id":"PMC_27073467","title":"miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.","date":"2016","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27073467","citation_count":16,"is_preprint":false},{"pmid":"33931142","id":"PMC_33931142","title":"S1PR1 signaling in cancer: A current perspective.","date":"2021","source":"Advances in protein chemistry and structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/33931142","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54326,"output_tokens":8152,"usd":0.142629},"stage2":{"model":"claude-opus-4-6","input_tokens":11989,"output_tokens":4138,"usd":0.245092},"total_usd":0.387721,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"EDG1/S1PR1 is a functional Gi/o-coupled GPCR for sphingosine-1-phosphate that activates phospholipase C, mobilizes intracellular Ca2+, activates Ras-MAPK, and inhibits adenylate cyclase; all responses are pertussis toxin-sensitive.\",\n      \"method\": \"Stable transfection in CHO and HEL cells, radioligand binding, pertussis toxin treatment, Ca2+ mobilization assay, IP production assay, MAPK activation assay, cAMP assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in heterologous cells with multiple orthogonal assays and pharmacological controls\",\n      \"pmids\": [\"9765227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"EDG1/S1PR1 couples preferentially to Gi (not Gq) as demonstrated in a Xenopus oocyte expression system; co-expression with chimeric Gαqi protein was required to confer S1P-responsive intracellular calcium transients, whereas EDG-3 and EDG-5 directly coupled to Gq pathway.\",\n      \"method\": \"Xenopus oocyte mRNA microinjection, chimeric G-protein co-expression, calcium transient recording\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — defined G-protein coupling via reconstitution with chimeric Gα proteins in a defined expression system\",\n      \"pmids\": [\"10383399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Ligand-induced trafficking of EDG-1/S1PR1: SPP specifically induces reversible receptor translocation from the plasma membrane to perinuclear endocytic vesicles/lysosomes (t1/2 ~15 min internalization, ~30 min recycling); C-terminal truncation completely blocks internalization.\",\n      \"method\": \"EDG-1-GFP chimera live imaging in HEK293 cells, colocalization with endocytic markers, SPP dose-response, C-terminal truncation mutants\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct live imaging with GFP chimera, domain mapping by truncation mutagenesis\",\n      \"pmids\": [\"10198065\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EDG1/S1PR1 mediates S1P-induced migration and Rac activation; Edg1-/- mouse embryonic cells fail to activate Rac in response to S1P and exhibit defective migration, leading to vascular maturation defects due to loss of vascular smooth muscle cells/pericytes.\",\n      \"method\": \"Germline knockout mouse model, vascular phenotyping, Rac GTPase activation assay, cell migration assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function in mice with defined cellular and molecular phenotype replicated across multiple assays; 977 citations\",\n      \"pmids\": [\"11032855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EDG1/S1PR1 (but not EDG5) signals via PI3-kinase and Rac to promote chemotaxis and membrane ruffling; EDG5 instead inhibits Rac by stimulating Rac-GTPase-activating protein activity, establishing receptor subtype-specific regulation of Rac.\",\n      \"method\": \"CHO cells stably expressing EDG1, EDG3, or EDG5; chemotaxis assay, membrane ruffle quantification, GTP-Rac pulldown, PI3K assay, pertussis toxin and dominant-negative Cdc42/Rho constructs\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution in defined cell lines with multiple signaling assays and dominant-negative constructs; 275 citations\",\n      \"pmids\": [\"11094076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Computational modeling and site-directed mutagenesis identified Arg120, Arg292 (ion-pairing with the phosphate of S1P), and Glu121 (ion-pairing with the ammonium group) as critical ligand-recognition residues of EDG-1/S1PR1.\",\n      \"method\": \"Computational homology modeling, site-directed mutagenesis, radioligand binding, [35S]GTPγS binding, receptor internalization assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — computational model validated by multiple functional mutagenesis assays\",\n      \"pmids\": [\"10982820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A single residue difference (Glu vs. Gln at the homologous position) determines ligand specificity between S1P1/EDG1 (Glu required for S1P recognition) and LPA1/EDG2; Glu/Gln interchange point mutants confirmed this prediction.\",\n      \"method\": \"Computational modeling, site-directed mutagenesis of S1P1 and LPA1, ligand-binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — structure-function mutagenesis with clear mechanistic interpretation\",\n      \"pmids\": [\"11604399\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"EDG1/S1PR1 phosphorylation and internalization are regulated by two independent mechanisms: agonist-induced GRK2 phosphorylation (on C-terminal serine/threonine residues) drives internalization, whereas PKC/PMA-induced phosphorylation causes surface loss via a distinct pathway; removal of 12 C-terminal residues specifically blocks agonist-mediated internalization but not PMA-mediated phosphorylation.\",\n      \"method\": \"Phosphoamino acid analysis, in vitro GRK2 kinase assay, C-terminal truncation mutants, surface expression assay in intact cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assay plus domain mutagenesis with multiple mechanistic readouts\",\n      \"pmids\": [\"11741892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"EDG-1/S1PR1 mediates S1P-induced cardiac myocyte hypertrophy primarily via Gi, activating ERK, p38 MAPK, JNK, PI3K/Akt, and Rho/actin stress fiber pathways; anti-EDG1 antibodies blocked S1P-induced hypertrophy in neonatal rat cardiomyocytes.\",\n      \"method\": \"Neonatal rat cardiomyocyte culture, anti-EDG1 antibody blocking, phospho-Western blot, kinase inhibitors, [3H]-phenylalanine incorporation, cell size measurement\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antibody blocking and kinase inhibitor pharmacology with multiple signaling readouts; single lab\",\n      \"pmids\": [\"11549339\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"EDG-1/S1PR1 is N-glycosylated at Asn30 in its extracellular N-terminus; this glycosylation is required for ligand-induced receptor internalization and for localization to caveolae microdomains, but not for ligand binding or MAPK activation.\",\n      \"method\": \"N30D mutagenesis, sucrose density gradient fractionation, ligand binding assay, MAPK activation assay, internalization assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-directed mutagenesis with multiple orthogonal functional assays\",\n      \"pmids\": [\"12087059\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"STAT3 directly transcribes the S1PR1 gene; S1PR1 reciprocally activates STAT3 by upregulating JAK2 tyrosine kinase activity, and S1P-S1PR1-induced STAT3 activation is persistent (vs. transient IL-6-induced activation), forming a positive feedback loop for sustained STAT3 activity in tumor cells.\",\n      \"method\": \"ChIP assay, siRNA knockdown, reporter assay, Western blot for JAK2/pSTAT3, tumor xenograft models\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP for direct transcription factor binding, functional rescue experiments, in vitro and in vivo models; 339 citations\",\n      \"pmids\": [\"21102457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GRK2 mediates agonist-induced S1PR1 desensitization on blood-exposed lymphocytes; GRK2 deficiency impairs lymphocyte movement from blood into lymphoid tissues, and this block is rescued in S1P-deficient mice. B cell movement between marginal zone and follicles requires GRK2-dependent S1PR1 desensitization.\",\n      \"method\": \"Conditional GRK2 knockout mice, adoptive transfer experiments, S1P-deficient mouse rescue, S1PR1 desensitization motif point mutant\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with conditional knockouts and point-mutant rescue; 170 citations\",\n      \"pmids\": [\"21960637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"S1PR1 on megakaryocytes directs proplatelet extension into bone marrow sinusoids by sensing the S1P gradient; conditional S1PR1-deficient mice develop severe thrombocytopenia due to aberrant extravascular proplatelet formation and defective intravascular shedding.\",\n      \"method\": \"Conditional knockout mice, intravital multiphoton microscopy, platelet counts, bone marrow histology\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with intravital imaging and defined cellular phenotype; 126 citations\",\n      \"pmids\": [\"23148237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Smad2/3 signaling in endothelial cells maintains vascular integrity by regulating S1PR1 and N-cadherin expression; endothelial-specific Smad2/3 double KO results in reduced S1PR1 expression, gaps between ECs and mural cells, and embryonic hemorrhage.\",\n      \"method\": \"Tie2-Cre conditional double knockout mice, immunostaining, Western blot for S1PR1 and adhesion proteins\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with molecular readout; single lab\",\n      \"pmids\": [\"22498737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"S1PR1-STAT3 signaling in myeloid cells enables intravasation and formation of premetastatic niches; targeting S1PR1 or STAT3 in myeloid cells disrupts existing premetastatic niches.\",\n      \"method\": \"Myeloid-specific conditional knockouts, flow cytometry, tumor metastasis models\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological targeting with mechanistic readout; single lab\",\n      \"pmids\": [\"22624714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"KLF2 transcriptionally drives S1PR1 expression in T cells; TGF-β, IL-33, and TNF suppress KLF2 via PI3K/Akt signaling, thereby downregulating S1PR1 and enabling tissue-resident memory CD8+ T cell establishment. Forced S1PR1 expression prevents TRM cell formation.\",\n      \"method\": \"Retroviral forced expression of S1PR1 in T cells, cytokine treatment, transcription factor knockdown, mouse adoptive transfer models\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — forced expression and genetic epistasis with defined transcriptional mechanism; 680 citations\",\n      \"pmids\": [\"24162775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"S1PR1 forms a complex with c-Met and integrin β4 in caveolin-enriched lipid rafts; HGF-induced c-Met activation leads to S1PR1 transactivation and Rac1 activation, which are rate-limiting for endothelial barrier enhancement.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown of S1PR1 and ITGB4, transendothelial electrical resistance measurement, c-Met inhibitor XL880\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal co-IP and siRNA with functional readout; single lab\",\n      \"pmids\": [\"23212923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling in T cells at low S1P concentrations near lymphoid organ exit sites; dynamin 2-deficient T cells can only generate a transient pulse of S1PR1 signaling insufficient for egress.\",\n      \"method\": \"T cell-specific dynamin 2 knockout mice, transgenic S1PR1 rescue, lymphocyte egress assay, thymus and lymph node cellularity\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined mechanistic rescue by S1PR1 overexpression; 40 citations\",\n      \"pmids\": [\"24638168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Tyrosine 143 phosphorylation of S1PR1 is required for agonist-induced receptor internalization in endothelial cells; Y143F (phospho-defective) fails to internalize, Y143D (phospho-mimicking) shows constitutive internalization; S1PR1 dephosphorylation at Y143 accompanies receptor recycling to the plasma membrane.\",\n      \"method\": \"Site-directed mutagenesis (Y143F, Y143D), flow cytometry for surface S1PR1, TEER measurement, phospho-specific analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis of PTM site with multiple functional readouts\",\n      \"pmids\": [\"25588843\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"S1PR1 agonism accelerates IFNAR1 turnover and suppresses STAT1 phosphorylation in plasmacytoid dendritic cells, thereby inhibiting the type I IFN autoamplification loop; this suppression is pertussis toxin-resistant but blocked by a C-terminal S1PR1 peptide that prevents receptor internalization, indicating internalization is required for the immunosuppressive mechanism.\",\n      \"method\": \"Pharmacological S1PR1 agonism and antagonism, Tat-fusion peptide blocking internalization, IFNAR1 turnover assay, pSTAT1 Western blot, in vivo CpG-A IFN-α induction\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal pharmacological tools and peptide-based mechanistic dissection with in vivo validation\",\n      \"pmids\": [\"26787880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"T cell-intrinsic S1PR1 is the master regulator of effector T cell sinus entry and egress from draining lymph nodes during infection; S1PR1-deficient effector T cells migrate normally within the paracortex but fail to enter lymphatic sinuses.\",\n      \"method\": \"Inducible T cell-specific S1PR1 knockout mice, two-photon intravital microscopy, adoptive transfer\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible conditional KO with direct intravital visualization of trafficking step\",\n      \"pmids\": [\"26862175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Moesin controls clathrin-mediated S1PR1 internalization in T cells; moesin-deficient T cells fail to form clathrin-coated vesicles and internalize S1PR1 upon S1P stimulation, resulting in delayed lymphopenia after FTY720 treatment and persistent S1P chemotaxis ex vivo.\",\n      \"method\": \"Moesin-deficient mice, FTY720 treatment, clathrin inhibitor, colocalization of S1PR1 with clathrin-coated vesicles/early endosomes, chemotaxis assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with pharmacological and mechanistic validation in vivo and ex vivo\",\n      \"pmids\": [\"24358210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"S1PR1 in tumor-associated macrophages promotes lymphangiogenesis and pulmonary metastasis via NLRP3 inflammasome activation and IL-1β production; conditional S1PR1 deletion in CD11bhi CD206+ TAMs reduces Nlrp3 expression and prevents metastasis.\",\n      \"method\": \"Myeloid-specific S1PR1 conditional knockout mice, transcriptome analysis of isolated TAMs, in vitro macrophage-lymphangiogenesis assay, inflammasome activation\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with transcriptomic and functional mechanistic follow-up\",\n      \"pmids\": [\"28739604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cryo-EM structures of S1PR1 and S1PR5 bound to diverse agonists and heterotrimeric Gi protein reveal: (1) distinct binding modes of chemically different agonists, (2) the mechanical switch that activates these receptors, and (3) the structural basis of G protein coupling and ligand selectivity.\",\n      \"method\": \"Cryo-electron microscopy structure determination, functional signaling assays\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple cryo-EM structures with orthogonal functional validation\",\n      \"pmids\": [\"34526663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CD69 acts as a protein agonist of S1PR1 in cis: cryo-EM structure of CD69-S1PR1-Gi complex shows the CD69 transmembrane helix contacts S1PR1-TM4, allosterically inducing TM5-6 movement to activate Gi coupling and promote receptor internalization and degradation, inhibiting lymphocyte egress.\",\n      \"method\": \"Cryo-EM structure determination, mutagenesis of interface residues, S1PR1 internalization assay, lymphocyte egress assay\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure plus mutagenesis and functional validation; defines novel protein agonist mechanism\",\n      \"pmids\": [\"37039481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Endothelial S1PR1 activates ERK signaling and upregulates CSF1 expression, promoting Ly6clow reparative macrophage proliferation via cell-contact manner, thereby ameliorating post-myocardial infarction cardiac remodeling.\",\n      \"method\": \"Endothelial-specific S1pr1 knockout mice, pharmacological S1PR1 activation, CSF1 blockade, flow cytometry, in vitro co-culture\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with pathway rescue experiment; single lab\",\n      \"pmids\": [\"32091582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Endothelial S1PR1 activates AKT/eNOS signaling, increasing NO production which inhibits cardiomyocyte hypertrophy and cardiac fibroblast activation; endothelial-specific S1pr1 deletion aggravates pressure overload-induced cardiac dysfunction.\",\n      \"method\": \"Endothelial-specific S1pr1 conditional KO mice, transverse aortic constriction model, in vitro AKT/eNOS pathway inhibition, NO measurement\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined pathway rescue; single lab\",\n      \"pmids\": [\"31854513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Hypothalamic S1PR1 in POMC neurons activates STAT3 and the melanocortin system to reduce food intake and increase energy expenditure; STAT3 in turn upregulates S1PR1 expression in a positive feedback loop; selective disruption of hypothalamic S1PR1 increases food intake.\",\n      \"method\": \"Intracerebroventricular S1P injection, selective hypothalamic S1PR1 disruption, STAT3 phosphorylation assay, food intake and energy expenditure measurement in rodents\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo gain/loss-of-function with mechanistic pathway definition; single lab\",\n      \"pmids\": [\"25255053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"miR302-367 reduces Erk1/2 in endothelial cells, which increases KLF2 expression, which in turn upregulates S1PR1 and VE-cadherin; genetic or pharmacological S1PR1 deletion reverses the anti-angiogenic and vascular-stabilizing effects of miR302-367.\",\n      \"method\": \"Endothelial-specific miR302-367 overexpression, S1PR1 conditional KO mice, pharmacological S1PR1 blockade, in vitro and in vivo angiogenesis assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via genetic KO rescue plus in vitro validation; single lab\",\n      \"pmids\": [\"27756792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"aPC activates PAR1 to recruit β-arrestin-2, which activates SphK1 independent of Dvl2; SphK1 then transactivates S1PR1 to activate Akt and protect endothelial cells from apoptosis. S1PR1 co-associates with caveolin-1, and aPC increases S1PR1/Cav1 association; this pathway is distinct from the PAR1-β-arr2-ERK1/2 pathway.\",\n      \"method\": \"siRNA knockdown of PAR1, S1PR1, SphK1, β-arrestin-2, Cav1; co-immunoprecipitation; apoptosis assay in human endothelial cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple siRNA knockdowns with co-IP and functional apoptosis readout; single lab\",\n      \"pmids\": [\"34873055\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"S1PR1 limits T cell apoptosis by maintaining BCL2 family balance via restraint of JNK activity; the same C-terminal residues required for receptor internalization are necessary for this anti-apoptotic function, linking internalization to survival signaling.\",\n      \"method\": \"S1PR1 internalization-defective mutants, JNK activity assay, BCL2 family protein expression, apoptosis assay, validation in ozanimod-treated ulcerative colitis patients\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis linking internalization to anti-apoptotic signaling with clinical translational validation\",\n      \"pmids\": [\"38194271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"S1PR1 (ortholog of Drosophila Tre1) is required for astrocyte process elaboration; loss of s1pr1 in zebrafish disrupts astrocyte process extension/retraction dynamics during growth, leading to defects in motor behavior.\",\n      \"method\": \"s1pr1 zebrafish knockout, live imaging of astrocyte process dynamics, pharmacological treatment, Drosophila Tre1 mutant analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO in zebrafish ortholog model with live imaging; evolutionarily conserved function\",\n      \"pmids\": [\"38096817\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"STAT1 transcription factor binds to the -29 to -12 bp minimal promoter region of S1PR1, directly stimulating S1PR1 expression; STAT1 knockdown reduces S1PR1 and overexpression or IFN-γ activation of STAT1 increases S1PR1 levels.\",\n      \"method\": \"EMSA, ChIP assay, promoter-reporter truncation analysis, STAT1 siRNA knockdown, IFN-γ stimulation\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — EMSA and ChIP with functional promoter mapping; single lab\",\n      \"pmids\": [\"32006593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCR7/CCL19 signaling upregulates EDG-1/S1PR1 expression in T cells via an ERK5-KLF2 pathway; ERK5 conditional deletion in T cells abolishes CCL19-stimulated S1PR1 upregulation and migration toward S1P.\",\n      \"method\": \"ERK5flox/flox/Lck-Cre conditional KO mice, human T cell line CCR7 stimulation, KLF2 and S1PR1 expression analysis, chemotaxis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined pathway; single lab\",\n      \"pmids\": [\"22334704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"IL-10 stimulation induces S1PR1 expression in lymph node T cells via STAT3-dependent signaling, promoting CD4+ T cell egress and peripheral nerve infiltration in autoimmune neuropathy.\",\n      \"method\": \"IL-10-deficient mice, IL-10 in vitro stimulation of lymph node cells, STAT3 inhibition, S1PR1 expression analysis, histological nerve infiltration assessment\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IL-10 KO mouse model with in vitro pathway dissection; single lab\",\n      \"pmids\": [\"29367208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"S1PR1/S1P/Sphk1 pathway differentially modulates CD4+ vs. CD8+ T cell alloreactivity by augmenting mitochondrial fission and increasing mitochondrial mass specifically in allogeneic CD4+ T cells via AMPK/AKT/mTOR/Drp1 signaling.\",\n      \"method\": \"Sphk1 and S1PR1 conditional knockouts, pharmacological inhibitors, GVHD mouse model, mitochondrial mass and fission assays, flow cytometry\",\n      \"journal\": \"Cellular & molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacologic loss-of-function with mechanistic pathway readout; single lab\",\n      \"pmids\": [\"36071219\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"S1PR1 (EDG-1) is a Gi-coupled GPCR for sphingosine-1-phosphate whose ligand-binding pocket is defined by Arg120, Arg292, and Glu121; upon S1P binding it activates Rac (via PI3K), MAPK, and AKT/eNOS while inhibiting adenylate cyclase, and undergoes GRK2- and Tyr143-phosphorylation-dependent clathrin/dynamin-2-mediated internalization (facilitated by moesin and N-glycosylation at Asn30) that is essential for lymphocyte egress from lymphoid organs, vascular maturation, thrombopoiesis, and energy homeostasis; its expression is transcriptionally driven by KLF2, STAT1, STAT3, and CCR7/ERK5/KLF2, and reciprocally S1PR1 sustains persistent STAT3 activation via JAK2 upregulation, forming a positive feedback loop that promotes tumor progression; additionally, CD69 acts as a protein agonist of S1PR1 by contacting TM4 to allosterically activate Gi coupling and promote receptor internalization.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"S1PR1 is a Gi-coupled GPCR for sphingosine-1-phosphate that orchestrates lymphocyte trafficking, vascular maturation, endothelial barrier function, and immune regulation by coupling extracellular S1P gradients to intracellular PI3K/Rac, MAPK, AKT/eNOS, and JAK2/STAT3 signaling cascades [PMID:9765227, PMID:11032855, PMID:21102457, PMID:31854513]. Ligand recognition depends on Arg120 and Arg292 (ion-pairing with the S1P phosphate head group) and Glu121 (contacting the ammonium group), as confirmed by mutagenesis and cryo-EM structures that further revealed the mechanical activation switch and Gi-coupling interface [PMID:10982820, PMID:34526663]. Agonist-induced internalization requires GRK2-mediated C-terminal phosphorylation, Tyr143 phosphorylation, moesin-dependent clathrin-coated vesicle formation, and dynamin-2-dependent endocytosis; this internalization is essential for lymphocyte egress from lymphoid organs, T cell survival via BCL2/JNK regulation, and suppression of type I interferon signaling [PMID:11741892, PMID:25588843, PMID:24358210, PMID:24638168, PMID:38194271, PMID:26787880]. S1PR1 expression is transcriptionally driven by KLF2, STAT1, and STAT3, while CD69 functions as an unconventional protein agonist that contacts TM4 to allosterically activate Gi coupling and trigger receptor downregulation, thereby blocking lymphocyte egress [PMID:24162775, PMID:32006593, PMID:21102457, PMID:37039481].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that EDG-1 is a bona fide Gi/o-coupled S1P receptor resolved the orphan receptor's identity and defined its core signaling repertoire (PLC, Ca²⁺, MAPK, adenylate cyclase inhibition).\",\n      \"evidence\": \"Reconstitution in CHO/HEL cells with radioligand binding, pertussis toxin sensitivity, and multiple second-messenger assays\",\n      \"pmids\": [\"9765227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream effectors beyond PLC/MAPK not yet mapped\", \"In vivo relevance of S1PR1 signaling unknown\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating exclusive Gi coupling (versus Gq for EDG-3/EDG-5) and agonist-induced internalization with C-terminal dependence established the receptor's subtype-specific G-protein selectivity and trafficking behavior.\",\n      \"evidence\": \"Xenopus oocyte chimeric Gα reconstitution for coupling specificity; GFP-tagged receptor live imaging and C-terminal truncation in HEK293 for internalization\",\n      \"pmids\": [\"10383399\", \"10198065\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase(s) mediating C-terminal phosphorylation unknown\", \"Endosomal fate and recycling mechanism not defined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Knockout mice and mutagenesis revealed that S1PR1 mediates Rac activation via PI3K to drive cell migration and vascular maturation, and identified Arg120/Arg292/Glu121 as the ligand-binding triad, connecting receptor structure to developmental phenotype.\",\n      \"evidence\": \"Edg1−/− mouse embryonic cells (Rac/migration defects, vascular smooth muscle loss); site-directed mutagenesis with radioligand and GTPγS binding; reconstitution in CHO cells for PI3K-Rac-chemotaxis axis\",\n      \"pmids\": [\"11032855\", \"10982820\", \"11094076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Gi engagement not yet visualized\", \"Tissue-specific roles beyond vasculature unexplored\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of GRK2 as the kinase driving agonist-induced internalization (distinct from PKC-mediated phosphorylation) and a single-residue determinant of S1P versus LPA selectivity established the mechanistic basis for receptor desensitization and ligand discrimination.\",\n      \"evidence\": \"In vitro GRK2 kinase assay and C-terminal truncation mutants; Glu/Gln interchange mutagenesis between S1P1 and LPA1\",\n      \"pmids\": [\"11741892\", \"11604399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo consequence of GRK2-dependent desensitization for lymphocyte trafficking not yet tested\", \"Complete phosphorylation site map lacking\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"N-glycosylation at Asn30 was shown to be required for ligand-induced internalization and caveolar localization but dispensable for ligand binding and MAPK signaling, dissociating surface signaling from endocytic trafficking.\",\n      \"evidence\": \"N30D mutagenesis with sucrose gradient fractionation, internalization, binding, and MAPK assays\",\n      \"pmids\": [\"12087059\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of caveolar versus clathrin-mediated endocytosis not resolved\", \"Glycosylation impact on in vivo receptor function untested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery of the S1PR1-STAT3 positive feedback loop — STAT3 transcribes S1PR1, and S1PR1 reciprocally sustains STAT3 via JAK2 upregulation — provided a mechanistic basis for persistent oncogenic STAT3 activation.\",\n      \"evidence\": \"ChIP for STAT3 on S1PR1 promoter, siRNA, reporter assays, JAK2/pSTAT3 Western blots, tumor xenografts\",\n      \"pmids\": [\"21102457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S1PR1 upregulates JAK2 at the molecular level unclear\", \"Whether feedback loop operates in all tumor types unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Genetic epistasis in conditional GRK2-knockout mice proved that GRK2-mediated S1PR1 desensitization on blood-exposed lymphocytes is required for lymphocyte entry into lymphoid tissues, connecting receptor desensitization to immune cell trafficking in vivo.\",\n      \"evidence\": \"Conditional GRK2 KO mice, adoptive transfer, rescue in S1P-deficient background, desensitization motif point mutant\",\n      \"pmids\": [\"21960637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site specificity for desensitization versus internalization not resolved\", \"Whether other GRKs contribute in vivo not excluded\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Multiple conditional knockout studies expanded S1PR1's physiological roles to megakaryocyte-directed thrombopoiesis, endothelial vascular integrity (downstream of Smad2/3), and T cell trafficking regulated by CCR7-ERK5-KLF2 transcriptional control of S1PR1 expression.\",\n      \"evidence\": \"Megakaryocyte-specific S1PR1 KO with intravital imaging (thrombocytopenia); endothelial Smad2/3 double KO with reduced S1PR1; ERK5-conditional KO in T cells abolishing CCL19-stimulated S1PR1 upregulation\",\n      \"pmids\": [\"23148237\", \"22498737\", \"22334704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling intermediates linking S1PR1 to proplatelet extension not mapped\", \"Direct Smad2/3 binding to S1PR1 promoter not shown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"KLF2 was identified as the key transcription factor driving S1PR1 expression in T cells, with TGF-β/IL-33/TNF suppressing KLF2 via PI3K/Akt to downregulate S1PR1, thereby enabling tissue-resident memory T cell formation; separately, moesin was shown to be required for clathrin-mediated S1PR1 internalization.\",\n      \"evidence\": \"Retroviral forced S1PR1 expression preventing TRM formation; moesin-KO mice with impaired clathrin-coated vesicle formation and S1PR1 internalization\",\n      \"pmids\": [\"24162775\", \"24358210\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct moesin-S1PR1 physical interaction not demonstrated\", \"How moesin specifically enables clathrin coat assembly on S1PR1 unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Dynamin-2-dependent endocytosis was shown to sustain S1PR1 signaling at low S1P concentrations near lymphoid exit sites, establishing that endosomal signaling (not just surface signaling) is required for lymphocyte egress.\",\n      \"evidence\": \"T cell-specific dynamin-2 KO mice with defective egress rescued by S1PR1 overexpression\",\n      \"pmids\": [\"24638168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endosomal signaling effectors downstream of internalized S1PR1 not identified\", \"Whether signaling endosomes carry Gi or switch to other effectors unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Tyr143 phosphorylation was identified as a required step for agonist-induced S1PR1 internalization, with phospho-mimetic (Y143D) causing constitutive internalization and phospho-dead (Y143F) blocking it, adding a tyrosine phosphorylation checkpoint to the GRK2/serine-threonine mechanism.\",\n      \"evidence\": \"Y143F/Y143D mutagenesis with flow cytometry and TEER in endothelial cells\",\n      \"pmids\": [\"25588843\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase phosphorylating Y143 not identified\", \"Relationship between Y143 phosphorylation and GRK2-mediated C-terminal phosphorylation unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"S1PR1 internalization was shown to suppress type I IFN signaling by accelerating IFNAR1 turnover independently of Gi (pertussis toxin-resistant), revealing an internalization-dependent immunomodulatory mechanism; simultaneously, KLF2-dependent S1PR1 expression downstream of miR302-367/ERK was linked to vascular stabilization.\",\n      \"evidence\": \"S1PR1 agonism with Tat-fusion peptide blocking internalization in pDCs; miR302-367 OE with S1PR1 conditional KO epistasis\",\n      \"pmids\": [\"26787880\", \"27756792\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which internalized S1PR1 promotes IFNAR1 degradation unknown\", \"Whether miR302-367-KLF2-S1PR1 axis operates outside developmental angiogenesis unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cryo-EM structures of S1PR1-Gi complexes provided atomic-level visualization of the ligand-binding pocket, the activation switch (TM5-6 rearrangement), and the Gi-coupling interface, validating decades of mutagenesis data; additionally, the S1PR1-STAT3 loop was extended to hypothalamic energy homeostasis and endothelial cardioprotection.\",\n      \"evidence\": \"Cryo-EM structures with diverse agonists; hypothalamic S1PR1 disruption altering food intake via STAT3; endothelial S1PR1-KO exacerbating cardiac remodeling with CSF1/macrophage and AKT/eNOS readouts\",\n      \"pmids\": [\"34526663\", \"25255053\", \"32091582\", \"31854513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of receptor activation in membrane environment not captured\", \"How S1PR1-STAT3 loop integrates with canonical JAK-STAT kinetics in neurons versus tumor cells unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CD69 was revealed as an unprecedented protein agonist of S1PR1: its TM helix contacts S1PR1-TM4 to allosterically activate Gi and drive internalization/degradation, providing the structural mechanism for CD69-mediated lymphocyte retention in tissues.\",\n      \"evidence\": \"Cryo-EM structure of CD69-S1PR1-Gi complex, interface mutagenesis, internalization and egress assays\",\n      \"pmids\": [\"37039481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other transmembrane proteins use a similar TM-contact agonism mechanism unknown\", \"In vivo stoichiometry and regulation of CD69-S1PR1 interaction not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"S1PR1 internalization was linked to T cell survival via BCL2 family balance and JNK restraint, with the same C-terminal residues required for internalization also necessary for anti-apoptotic function, unifying trafficking and survival signaling.\",\n      \"evidence\": \"Internalization-defective mutants, JNK/BCL2 assays, validation in ozanimod-treated ulcerative colitis patients\",\n      \"pmids\": [\"38194271\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct endosomal signaling intermediates linking internalized S1PR1 to JNK suppression not identified\", \"Whether anti-apoptotic function is Gi-dependent or Gi-independent not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the kinase phosphorylating Tyr143, the precise endosomal signaling complex composition after S1PR1 internalization, and whether the CD69 protein-agonist paradigm extends to other GPCRs.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Y143 kinase identity unknown\", \"Endosomal signaling effectors of internalized S1PR1 not characterized\", \"Structural basis of S1PR1-JAK2 upregulation mechanism undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 23, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 9, 18]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2, 21]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [2, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 8, 10, 23, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [11, 15, 17, 20, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 13, 28]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [10, 14, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GRK2\",\n      \"STAT3\",\n      \"CD69\",\n      \"KLF2\",\n      \"MSN\",\n      \"DNM2\",\n      \"SPHK1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}